Lucker GP et al, 1995
Images (1)
Porokeratosis ptychotropicaQ82.8
HistoryThis section has been translated automatically.
DefinitionThis section has been translated automatically.
Very rare, clinical (inverse) manifestation form of disseminated superficial porokeratosis (from ptych=fold) with involvement of the major body folds (see porokeratoses below).
Occurrence/EpidemiologyThis section has been translated automatically.
m>w
EtiopathogenesisThis section has been translated automatically.
Unknown. A genetic predisposition has not been proven to date. Other forms of porokeratosis have been associated with risk factors such as UV irradiation, trauma, renal and liver failure, organ transplantation, and immunosuppression.
ManifestationThis section has been translated automatically.
The mean age of onset is 46.7 years (the reported age range is 27-84 years) (Takiguchi RH et al. 2009).
LocalizationThis section has been translated automatically.
The skin lesions often involve the gluteal folds and the perianal region.
Clinical featuresThis section has been translated automatically.
In disseminated, but also areal distribution, reddened, or also non-inflammatory brown-yellowish, slightly scaly, also warty, flat raised papules and plaques are found. Itching has been reported.
DiagnosisThis section has been translated automatically.
Bioptic confirmation of the diagnosis. Histologically groundbreaking is the detection of a cornoid lamella. This is a parakeratotic column overlying a small vertical zone of dyskeratotic and vacuolated cells within the epidermis.
Differential diagnosisThis section has been translated automatically.
Psoriasis inversa
Dyskeratosis follicularis
Tinea corporis
Intertrigo
General therapyThis section has been translated automatically.
There is no known cure for porokeratosis ptychotropica, and the results of treatment are generally disappointing. The appearance may improve with the following:
5-fluorouracil cream
Imiquimod cream
Calcipotriol cream
Isotretinoin
Individual foci can also be treated with cryosurgery or dermabrasion. Ablative laser systems may also be used.
Clinical monitoring is recommended, as the risk of malignant transformation cannot be excluded.
LiteratureThis section has been translated automatically.
- Feng Y et al.(2021) Porokeratosis ptychotropica on the buttocks. Indian J Dermatol Venereol Leprol 7:1.
- Lacarrubba F et al. (2021) Porokeratosis ptychotropica: Dermoscopy, Reflectance Confocal Microscopy, and Histopathological Correlation. Indian J Dermatol 66: 540-542.
- Liu P et al. (2008) Identification of a genetic locus for autosomal dominant disseminated superficial actinic porokeratosis on chromosome 1p31.3-p31.1. Hum Genet 123:507-513.
- Lucker GPet al (1995) An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br J Dermatol 132: 150-151.
- McGuigan K et al (2009) Porokeratosis ptychotropica: a clinically distinct variant of porokeratosis. J Am Acad Dermatol 60: 501-503.
- Takiguchi RH et al (2009) Verrucous porokeratosis of the gluteal cleft (porokeratosis ptychotropica): a rare condition that is easily misdiagnosed. J Cutan Pathol 37: 802-807.
- Tebet AC et al (2016) Porokeratosis ptychotropica. An Bras Dermatol 91: 134-136.
- Xia K et al (2002) A novel locus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1-26.1. Br J Dermatol 147:650-654.